- AVCN completes first commercial export of evidence-based derma-cosmetic line Pura H&W into the European market
- Pura Health & Wellness (Pura H&W) is Avicanna’s derma-cosmetic line utilizing a combination of purified CBD and other synergistic botanical ingredients designed to naturally regulate and nourish the skin
- Avicanna carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates
- Avicanna Inc. (AVCN) was trading at C$0.24 as of 1:48 p.m. EDT
Avicanna (AVCN) has completed the first commercial export of its dermo-cosmetic line Pura H&W into the European Market.
This export is tied to its supply and distribution agreement with Bio-Gate AG.
Avicanna’s evidence-based derma-cosmetics portfolio has now been successfully imported into Germany where Bio-Gate prepare to launch this summer. The portfolio of products will initially be available on its website and then further expanded into other online, retail, and pharmacy channels across Germany, Austria, and Switzerland during 2022.
Jens Kramer, VP of European Operations at Avicanna, commented on the news.
“We are pleased to be entering the European market with our first line of branded products and to be doing so in collaboration with Bio-Gate. Both teams are excited about the launch of the skincare portfolio in the coming months and are happy to see the Pura Health and Wellness brand establish a new European foothold.”
To its knowledge, Avicanna carries out its operations in compliance with all applicable laws in the jurisdictions in which it operates.
Avicanna Inc. (AVCN) was trading at C$0.24 as of 1:48 p.m. EDT.
